Bronchoconstriction and endogenous nitric oxide in isolated lungs of spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 488, Issue 1-3, 2004, Pages 181-189

  Kwasniewski, Fábio H ^a   Landgraf, Richardt Gama ^a   Bakhle, Yeshwant S ^b   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anaphylaxis; Bronchoconstriction; Lung; Mast cell; NO (Nitric oxide); Rat; Spontaneously hypertensive

Indexed keywords

ARACHIDONIC ACID; COMPOUND 48-80; METHACHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN H; SEROTONIN;

AIRWAY; AIRWAY CONSTRICTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; LUNG; LUNG COMPLIANCE; MALE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CELL DEGRANULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERSENSITIVITY; LUNG; MALE; MAST CELLS; METHACHOLINE CHLORIDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVALBUMIN; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 1642358233     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.005     Document Type: Article

References (32)

1. Belvisi M.G., Stretton C., Barnes P.J. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea pig airways. Eur. J. Pharmacol. 198:1991;219-221.
2. Black J. The role of mast cells in the pathophysiology of asthma. N. Engl. J. Med. 346:2002;1742-1743.
3. Brovkovych V., Dobrucki L.W., Brovkovych S., Dobrucki I., Do Nascimento C.A., Burewicz A., Malinski T. Nitric oxide release from normal and dysfunctional endothelium. J. Physiol. Pharmacol. 50:1999;575-586.
4. Chang H.R., Lee R.P., Wu C.Y., Chen H.I. Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin. Exp. Pharmacol. Physiol. 29:2002;275-280.
5. Coleman J.W. Nitric oxide: a regulator of mast cell activation and mast cell mediated inflammation. Clin. Exp. Immunol. 129:2002;1-10.
6. Eastmond N.C., Banks E.M.S., Coleman J.W. Nitric oxide inhibits IgE-mediated degranulation of mast cell and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159:1997;1444-1450.
7. Ellis J.L., Undem B.J. Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway. Am. Rev. Respir. Dis. 146:1992;1543-1547.
8. Forsythe P., Gilchrist M., Kulka M., Befus A.D. Mast cells and nitric oxide: control of production, mechanisms of response. Int. Immunopharmacol. 1:2001;1525-1541.
9. Gaboury J.P., Niu X.-F., Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 93:1996;318-326.
10. Gilchrist M., Savoie M., Nohara O., Wills F.L., Wallace J.L., Befus A.D. Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J. Leukoc. Biol. 71:2002;618-624.
11. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 39:1999;191-220.
12. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol. 53:2002;503-514.
13. Iikura M., Takaishi T., Hirai K., Yamada H., Iida M., Koshino T., Morita Y. Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells. Int. Arch. Allergy Immunol. 115:1998;129-136.
14. Kakuyama M., Ahluwalia A., Rodrigo J., Vallance P. Cholinergic contraction is altered in nNOS knockouts. Cooperative modulation of neural bronchoconstriction by nNOS and cyclooxygenase. Am. J. Respir. Crit. Care Med. 160:1999;2072-2078.
15. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 15:1990;475-481.
16. Kubes P., Kanwar S., Niu X.-F., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
17. Kumar U., Shin Y., Wersinger C., Patel Y., Sidhu A. Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive rat. Clin. Exp. Hypertens. 25:2003;271-282.
18. Kwasniewski F.H., Tavares de Lima W., Bakhle Y.S., Jancar S. Impairment in connective tissue mast cells degranulation in spontaneously hypertensive rats: stimulus dependent resistance. Br. J. Pharmacol. 124:1998;772-778.
19. 2 selective receptor antagonists. Eur. J. Pharmacol. 460:2003;75-83.
20. Liu H., Ledingham J.M., Mullaney I., Laverty R. Endothelial function in mesenteric resistance arteries from the genetically hypertensive rat. Clin. Exp. Pharmacol. Physiol. 29:2002;405-411.
21. Masini E., Mannaioni P.F., Pistelli A., Salvemini D., Vane J. Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 177:1991;1178-1182.
22. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
23. Meurs H., Maarsingh H., Zaagsma J. Arginase and asthma; novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 24:2003;450-455.
24. Nijkamp F.P., Folkerts G. Nitric oxide and bronchial hyperresponsiveness. Arch. Int. Pharmacodyn. Ther. 329:1995;81-96.
25. Page S., Ammit A.J., Black J.L., Armour C.L. Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am. J. Physiol., Lung Cell. Mol. Physiol. 281:2001;L1313-L1323.
26. Rossi G.L., Olivieri D. Does the mast cell still have a key role in asthma? Chest. 112:1997;523-529.
27. Salvemini D., Masini E., Pistelli A., Mannaioni P.F., Vane J. Nitric oxide: a regulatory mediator of mast cell reactivity. J. Cardiovasc. Pharmacol. 17(Suppl. 3):1991;S258-S264.
28. Spicuzza L., Basile L., Belvisi M.G., Bellofiore S., Matera M.G., Cazzola M., Di Maria G.U. The protective role of epithelium-derived nitric oxide in isolated bovine trachea. Pulm. Pharmacol. Ther. 15:2002;357-362.
29. Sunano S., Watanabe H., Tanaka S., Sekiguchi F., Shimamura K. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br. J. Pharmacol. 126:1999;709-716.
30. Touyz R.M., Deschepper C., Park J.B., He G., Chen X., Neves M.F., Virdis A., Schiffrin E.L. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J. Hypertens. 20:2002;1127-1134.
31. Yokota Y., Imaizumi Y., Asano M., Matsuda T., Watanabe M. Endothelium-derived relaxing factor released by 5-HT: distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br. J. Pharmacol. 113:1994;324-330.
32. Williams C.M., Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192:2000;455-462.